Barclays »

Estrella Immunopharma shares owned by Barclays

Quarter-by-quarter ownership of Estrella Immunopharma (ESLA) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Estrella Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Estrella Immunopharma held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Estrella Immunopharma by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $131 126 1.04

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding Estrella Immunopharma

Armistice Capital
Vanguard Capital Management
Geode Capital Management
Vanguard Fiduciary Trust
BlackRock
State Street Corporation
Renaissance Technologies
Northern Trust
Us Bancorp
Tower Research Capital
UBS Group
Toronto-Dominion Bank
Wolverine Asset Management
Barclays
Caitong International Asset Management

View all funds holding Estrella Immunopharma